Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
202
datasets available to search
ShareScore release 0.9.0
Dataset results
202 results for “exercise test”
CArdio PulmOnary Exercise Testing and IntRAvenous Iron- 'CAPOEIRA-I STUDY'
ClinicalTrials.gov study NCT03346213. IPD Sharing: NO. Countries: 1. Publications: 0.
Can Imaging be an Alternative to Exercise Testing as a Predictor of Surgical Fitness?
ClinicalTrials.gov study NCT06544187. IPD Sharing: NO. Countries: 1. Publications: 0.
The Registry Study to Compare the Cardiopulmonary Exercise Test Parameters Before and After Cardiac Rehabilitation in Patients With Chronic Total Occlusion of the Coronary Arteries
ClinicalTrials.gov study NCT03221712. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Micra AV Tracking During Exercise Testing
ClinicalTrials.gov study NCT05966168. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Benefit of Exercise Testing for the Diagnosis of Obstruction in the Coronary Arteries of the Heart
ClinicalTrials.gov study NCT05140434. IPD Sharing: NO. Countries: 1. Publications: 0.
Exercise Testing After Preeclampsia
ClinicalTrials.gov study NCT06741436. IPD Sharing: NO. Countries: 1. Publications: 0.
Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study
ClinicalTrials.gov study NCT01658982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients
ClinicalTrials.gov study NCT01745666. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing
GEO Series GSE128078. Homo sapiens. 99 samples. Type: Expression profiling by high throughput sequencing.
The Prospects of the Two-day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis
<p><strong>Supplementary Tables and Figure for "The Prospects of the Two-day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis"</strong></p>
The Effects of Breathing Exercises Administered to Associate Degree Students on Test Anxiety and Academic Achievement
ClinicalTrials.gov study NCT07145021. IPD Sharing: NO. Countries: 0. Publications: 0.
Comparison of E-Learning and Face-to-Face Learning in Cardiopulmonary Exercise Test Training
ClinicalTrials.gov study NCT06330285. IPD Sharing: NO. Countries: 0. Publications: 0.
Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis
ClinicalTrials.gov study NCT07383740. IPD Sharing: NO. Countries: 0. Publications: 0.
Cardiopulmonary Exercise Test to Quantify Enzyme Replacement Response in Pediatric Pompe Disease
ClinicalTrials.gov study NCT03147664. IPD Sharing: NO. Countries: 0. Publications: 0.
Testing a Tailored Home Exercise Program to Reduce Pain and Fatigue in Patients with FSHD.
ClinicalTrials.gov study NCT06712043. IPD Sharing: NO. Countries: 0. Publications: 0.
cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances
ClinicalTrials.gov study NCT05429359. IPD Sharing: NO. Countries: 0. Publications: 0.
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing
ClinicalTrials.gov study NCT03625843. IPD Sharing: NO. Countries: 0. Publications: 0.
Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer
ClinicalTrials.gov study NCT03215459. IPD Sharing: NO. Countries: 0. Publications: 0.
Raw data: Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension
<p>Periodic repetition of right heart catheterization (RHC) in pulmonary arterial hypertension (PAH) can be challenging. We evaluated the correlation between RHC and cardiopulmonary exercise test (CPET) aiming at CPET use as a potential noninvasive tool for hemodynamic burden evaluation. One hundred and forty‐four retrospective PAH patients who had performed CPET and RHC within 2 months were enrolled. The following analyses were performed: (a) CPET parameters in hemodynamic variables tertiles; (b) position of hemodynamic parameters in the peak end‐tidal carbon dioxide pressure (P<sub>ET</sub>CO<sub>2</sub>) versus ventilation/carbon dioxide output (VE/VCO<sub>2</sub>) slope scatterplot, which is a specific hallmark of exercise respiratory abnormalities in PAH; (c) association between CPET and a hemodynamic burden score developed including mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), cardiac index, and right atrial pressure. VE/VCO<sub>2</sub> slope and peak P<sub>ET</sub>CO<sub>2</sub> significantly varied in mPAP and PVR tertiles, while peak oxygen uptake (peak VO<sub>2</sub>) and O<sub>2</sub> pulse varied in the tertiles of all hemodynamic parameters. P<sub>ET</sub>CO<sub>2</sub> versus VE/VCO<sub>2</sub> slope showed a strong hyperbolic relationship (<em>R</em> <sup>2</sup> =&thinsp;0.7627). Patients with peak P<sub>ET</sub>CO<sub>2</sub> > median (26 mmHg) and VE/VCO<sub>2</sub> slope < median (44) presented lower mPAP and PVR (p < 0.005) than patients with peak P<sub>ET</sub>CO<sub>2</sub> < median and VE/VCO<sub>2</sub> slope > median. Multivariate analysis individuated peak VO<sub>2</sub> (<em>p</em> =&thinsp;0.0158) and peak P<sub>ET</sub>CO<sub>2</sub> (<em>p</em> =&thinsp;0.0089) as hemodynamic score independent predictors; the formula 11.584 − 0.0925 × peak VO<sub>2</sub> − 0.0811 × peak P<sub>ET</sub>CO<sub>2</sub> best predicts the hemodynamic score value from CPET data. A significant correlation was found between estimated and calculated scores (<em>p</em> < 0.0001), with a precise match for patients with mild‐to‐moderate hemodynamic burden (76% of cases). The results of the present study suggest that CPET could allow to estimate the hemodynamic burden in PAH patients.</p> <p> </p>
RAW DATA of the paper IMPROVEMENT OF FUNCTIONAL CAPACITY IN SACUBITRIL-VALSARTAN TREATED PATIENTS ASSESSED BY CARDIOPULMONARY EXERCISE TEST
<p>Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, i.e. ARNI) is recommended in heart failure guidelines for patients in NYHA class II-III with reduced left ventricular ejection fraction (LVEF). ARNI increase survival and quality of life; due to their hemodynamic effects, ARNI could also affect exercise tolerance. We studied the effects of ARNI on cardiopulmonary test (CPET) after six months of treatment in 35 patients [67±11 years; LVEF 31±6%; NT-proBNP 1822±1651 pg/ml; ICD/CRT since at least 6 months in 26/35], treated with increasing doses of Sacubitril/Valsartan up to 318±36 mg/die. In addition, levels of NT-proBNP, renal function, electrolytes, and echocardiocolorDoppler were assessed in the same time periods. No variations of renal function and/or potassium levels were observed; NT-proBNP decreased. Most CPET variables were improved by ARNI (p<0.05): peak VO<sub>2</sub> and O<sub>2</sub> pulse increased (from 15.8±3.4 to 17.0±4.0 ml/Kg/min and from 11.5±2.5 to 12.6±2.4 ml/beat, respectively), while VEVCO<sub>2</sub> slope decreased from 35.2±11.2 to 33.1±12.3. A significant relationship (p<0.05) was observed between the amount of increase in LVEF and that of O<sub>2</sub> pulse in all patients, and between the amount of decrease in PAPs and that of VEVCO<sub>2</sub> slope in patients showing pulmonary hypertension in baseline. In a subgroup of 22 patients who already completed A 1 year follow-up, overall CPET improvement was maintained. In conclusion, already in the short term ARNI favorably affect cardiopulmonary response to exercise in heart failure patients; such a change seems to be preserved on a longer period.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.